# Targeting Heightened Inflammatory Tone in IUGR Neonatal Lambs via Daily Oral Supplementation of ω-3 PUFA Improved Growth Rates, Muscle Mass, and Adiponectin Signaling

**Authors:** Melanie R. White, Rachel L. Gibbs, Pablo C. Grijalva, Zena M. Herrera, Shelley A. Curry, Haley N. Beer, Eileen S. Marks-Nelson, Dustin T. Yates

PMC · DOI: 10.3390/metabo16020136 · Metabolites · 2026-02-17

## TL;DR

Supplementing ω-3 PUFA in IUGR lambs improved growth, muscle mass, and adiponectin signaling by reducing inflammation.

## Contribution

Daily oral ω-3 PUFA supplementation resolves growth deficits in IUGR lambs by targeting neonatal inflammation.

## Key findings

- ω-3 PUFA supplementation fully resolved bodyweight deficits in IUGR lambs by day 28.
- ω-3 PUFA improved subcutaneous fat, visceral organ growth, and skeletal muscle mass in IUGR lambs.
- ω-3 PUFA restored myoblast populations and AdipoR2 content, resolving asymmetric growth restriction.

## Abstract

Background/Objectives: Circulating inflammatory cytokines and tissue sensitivity are both elevated following heat stress-induced intrauterine growth restriction (IUGR). Cytokines disrupt myoblast function and muscle growth, and thus we hypothesized that suppressing inflammatory tone in IUGR-born lambs by supplementing anti-inflammatory nutraceuticals would improve early postnatal growth. Methods: IUGR lambs produced by maternal heat stress were supplemented daily with 42 mg/kg oral omega-3 polyunsaturated fatty acid (ω-3 PUFA) Ca2+ salts or placebo from birth to 28 days of age. Results: By day 28, the 21% lighter bodyweights for IUGR lambs were fully resolved by ω-3 PUFA due to the complete recovery of average daily gain. Subcutaneous fat deposition and visceral organ growth were modestly diminished in IUGR-born lambs, but skeletal muscle mass was more markedly restricted. This coincided with 63% less muscle AdipoR2 but 27% greater circulating adiponectin. ω-3 PUFA reduced or eliminated deficits in subcutaneous fat, visceral organs, and five of the six individual muscles assessed, which corresponded with rescue of myoblast populations and AdipoR2 content. In turn, asymmetric growth restriction was resolved at one month of age. Conclusions: These findings show that targeting heightened inflammatory tone during the neonatal period in IUGR-born offspring can recover early growth in skeletal muscle and other soft tissues.

## Linked entities

- **Proteins:** ADIPOR2 (adiponectin receptor 2)
- **Chemicals:** omega-3 polyunsaturated fatty acid (PubChem CID 56842239)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CDH-13 [NCBI Gene 101123062], IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, TNFalpha [NCBI Gene 443540], INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, IGF-1 [NCBI Gene 443318], Adiponectin [NCBI Gene 101111848], Pax7 [NCBI Gene 101106413], CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, AdipoR2 [NCBI Gene 101116044], IL6R [NCBI Gene 101103369], ADIPOR2 (adiponectin receptor 2) [NCBI Gene 79602] {aka ACDCR2, PAQR2}, protease [NCBI Gene 114115257]
- **Diseases:** growth deficits (MESH:D006130), hyperlipidemia (MESH:D006949), IUGR (MESH:D005317), poor body composition (MESH:C564221), injury to (MESH:D014947), Inflammatory (MESH:D007249), impairments in glucose metabolism (MESH:D044882), hypoxic (MESH:D002534), hypo (MESH:D052456), obesity (MESH:D009765), hypoxemia (MESH:D000860), reduction of muscle mass (MESH:C536030), maternal hyperthermia (MESH:D005334), adrenergic dysregulation (MESH:D021081), metabolic disorders (MESH:D008659), muscle hypertrophy (MESH:C536106), hypertension (MESH:D006973), placental insufficiency (MESH:D010927), insulin resistance (MESH:D007333), hypertrophy (MESH:D006984), hypoglycemia (MESH:D007003), adiposity (MESH:D018205), type 2 diabetes (MESH:D003924), overdose (MESH:D062787)
- **Chemicals:** NaCl (MESH:D012965), OCT (MESH:C051883), triglyceride (MESH:D014280), EDTA (MESH:D004492), nitrogen (MESH:D009584), water (MESH:D014867), EPA (MESH:D015118), AlexaFluor 555 (MESH:C000608607), SDS (MESH:D012967), barbiturate (MESH:C032232), Mini-PROTEAN TGX (-), carbohydrate (MESH:D002241), oil (MESH:D009821), fatty acid (MESH:D005227), acylcarnitines (MESH:C116917), docosahexaenoic acid (MESH:D004281), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), citric acid (MESH:D019343), DHA (MESH:C027493), DAPI (MESH:C007293), poly-vinylidene fluoride (MESH:C024865), tween (MESH:D011136)
- **Species:** Ovis aries (domestic sheep, species) [taxon 9940], Sus scrofa (pig, species) [taxon 9823], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942730/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942730/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942730/full.md

---
Source: https://tomesphere.com/paper/PMC12942730